Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia.
Sector for Biostatistics & Data Repository, National Institutes of Health, Ministry of Health, Shah Alam 40170, Selangor, Malaysia.
Medicina (Kaunas). 2022 May 12;58(5):656. doi: 10.3390/medicina58050656.
Background and Objectives: Globorisk is a well-validated risk prediction model that predicts cardiovascular disease (CVD) in the national population of all countries. We aim to apply the Globorisk calculator and provide the overall, sex-specific, ethnic-specific, region-specific, and state-specific 10-year risk for CVD among Malaysian adults. Materials and Methods: Using Malaysia’s risk factor levels and CVD event rates, we calculated the laboratory-based and office-based risk scores to predict the 10-year risk for fatal CVD and fatal plus non-fatal CVD for the Malaysian adult population. We analysed data from 8253 participants from the 2015 nationwide Malaysian National Health and Morbidity Survey (NHMS 2015). The average risk for the 10-year fatal and fatal plus non-fatal CVD was calculated, and participants were further grouped into four categories: low risk (<10% risk for CVD), high risk A (≥10%), high risk B (≥20%), and high risk C (≥30%). Results: Results were reported for all participants and were then stratified by sex, ethnicity, region, and state. The average risks for laboratory-based fatal CVD, laboratory-based fatal plus non-fatal CVD, and office-based fatal plus non-fatal CVD were 0.07 (SD = 0.10), 0.14 (SD = 0.12), and 0.11 (SD = 0.09), respectively. Conclusions: There were substantial differences in terms of the sex-, ethnicity- and state-specific Globorisk risk scores obtained.
Globorisk 是一个经过充分验证的风险预测模型,可预测所有国家的国家人群的心血管疾病(CVD)风险。我们旨在应用 Globorisk 计算器,并提供马来西亚成年人 CVD 的总体、性别特异性、种族特异性、地区特异性和州特异性 10 年风险。
我们使用马来西亚的风险因素水平和 CVD 事件发生率,计算了基于实验室和基于办公室的风险评分,以预测马来西亚成年人群致命 CVD 和致命加非致命 CVD 的 10 年风险。我们分析了来自 2015 年全国马来西亚国家健康和发病率调查(NHMS 2015)的 8253 名参与者的数据。计算了 10 年致命和致命加非致命 CVD 的平均风险,参与者进一步分为四组:低风险(CVD 风险<10%)、高风险 A(≥10%)、高风险 B(≥20%)和高风险 C(≥30%)。
报告了所有参与者的结果,然后按性别、种族、地区和州进行分层。基于实验室的致命 CVD、基于实验室的致命加非致命 CVD 和基于办公室的致命加非致命 CVD 的平均风险分别为 0.07(SD = 0.10)、0.14(SD = 0.12)和 0.11(SD = 0.09)。
基于实验室的致命 CVD、基于实验室的致命加非致命 CVD 和基于办公室的致命加非致命 CVD 的 Globorisk 风险评分在性别、种族和州方面存在显著差异。